acetyl l carnitine and myasthenia gravis Complementing Treatments for Myasthenia Gravis

(4) treated with L-Carnitine (10 mg/kg)

The plate was placed into a 37 C incubator for 1 hour before 2 L of a 10 M dHTC3 solution in RPMI with 10% FBS was added to each well, and the plate was again placed on an orbital shaker for 15 seconds (final concentration of dHTC3 is 1 M, control wells are treated with an equal volume of DMSO in RPMI with 10% FBS)

The reasons for the differential behavior of the dicarboxylic carrier in kidney and liver are unknown and probably reflect that interorgan or intercellular differences may exist regarding mGSH transport

These disorders interfere with normal development of language and socialization